Insight Molecular grants stock options to four executives, amends CSO employment to indefinite term

Insight Molecular Diagnostics Inc.

Stock options: CEO Riggs 400k shares; CFO James and CSO Schütz 235k each; VP Liu 18k; exercise price $3.33.
Options vest over 3 years: 1/3 on first anniversary, then monthly over next 2 years, subject to continued service.
CSO Schütz's employment term amended from fixed 4-year to indefinite until termination; effective Sept 29, 2025.
Amendment removes references to 'Term Expiration' from severance provisions; all other terms unchanged.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.